Sarah Thom

Sarah is the Chief Financial Officer of Cochlear Limited, a global leader in implantable hearing solutions, developing and manufacturing electronic hearing devices, including cochlear implants, bone conduction implants, and acoustic implants, with a mission to help people hear and be heard.

Prior to Cochlear, Sarah was a Managing Director and Partner at Boston Consulting Group (BCG) and co-lead of BCG’s healthcare business in Australia and New Zealand. In her decade+ with BCG in Australia, she advised clients including health care payers and providers, biomed and medtech businesses, State and Commonwealth government agencies, energy businesses, infrastructure developers and operators, major resource companies, and financial services businesses. She has deep experience defining and delivering large-scale reform and innovation across complex organisations and ecosystems. Sarah has particular expertise in strategy development, data-driven reform design and delivery, digital transformation, major transactions and investment decisions, and operating model and org design.

Sarah holds a PhD in astrophysics from the University of Chicago, and a B.S. in physics from the University of Michigan. Prior to joining BCG, she was a research scientist awarded a US National Science Foundation Astronomy & Astrophysics Postdoctoral Fellowship at the University of California supporting her work on cosmology and galaxy evolution.

Dr Thom joined the Children's Medical Research Institute Board in November 2023 and is Chair of the Institute’s ProCan Oversight Committee.